Placebo use in vaccine trials: Recommendations of a WHO expert panel

Vaccines are among the most cost-effective interventions against infectious diseases. Many candidate vaccines targeting neglected diseases in low- and middle-income countries are now progressing to large-scale clinical testing. However, controversy surrounds the appropriate design of vaccine trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Rid, Annette, Saxena, Abha, Baqui, Abdhullah H., Bhan, Anant, Bines, Julie, Bouesseau, Marie-Charlotte, Caplan, Arthur, Colgrove, James, Dhai, Ames, Gomez-Diaz, Rita, Green, Shane K., Kang, Gagandeep, Lagos, Rosanna, Loh, Patricia, London, Alex John, Mulholland, Kim, Neels, Pieter, Pitisuttithum, Punee, Sarr, Samba Cor, Selgelid, Michael, Sheehan, Mark, Smith, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2014
Materias:
WHO report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157320/
https://www.ncbi.nlm.nih.gov/pubmed/24768580
http://dx.doi.org/10.1016/j.vaccine.2014.04.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157320/
https://www.ncbi.nlm.nih.gov/pubmed/24768580
http://dx.doi.org/10.1016/j.vaccine.2014.04.022

Ejemplares similares